Evaluation of combined pathological responses in primary tumor and lymph nodes following neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
Huang S, Wu J, Li S, Li X, Zeng R, Tang Y, Tang J, Ben X, Zhang D, Xie L, Zhou H, Chen G, Wang S, Gao Z, Wu H, Chen R, Xu F, Qiao G.
Huang S, et al. Among authors: wu h, wu j.
Lung Cancer. 2023 Dec;186:107401. doi: 10.1016/j.lungcan.2023.107401. Epub 2023 Oct 12.
Lung Cancer. 2023.
PMID: 37844351